chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had "expected" reactions the day following my second dose, which included body aches, fatigue, and a headache. However, on the second day I awoke with severe arm and underarm pain. I noticed that my left underarm was swollen, in my armpit area. A few hours later, I noticed that I had a large lump on my chest as well, also on the left side nearest the arm the vaccine was injected. From what I could determine from online searching, these 2 areas are swollen lymph nodes. I contacted my doctor via telephone, and they instructed me to take allergy medicine and Ibuprofen during the daytime, and to take Benadryl at night. I have taken Claritin for 2 days, along with the Ibuprofen every 5-6 hours. The swelling on my chest has gone down some, however my armpit is still swollen and hurts when I move my arm. The pain is all around my upper arm, under arm, chest, upper back/shoulder region, and the area near my ribs under my left arm. I am going to continue taking the medications recommended, and if the swelling has not gone down in about a week, my doctor instructed me to come into the office so it can be checked.
Rec'd vaccine Sunday @ 11:30AM, Reaction Tuesday @ 19:30, Arms started trembling,increased temperature,BP, HR,RR, Notified MD, 911 called , taken to hospital, Seizure continus, Rectal temp at hosp - 104.6@ 9:45PM. Motrin liquid & Tylenol suppository given, X-ray,cultures done - all neg
p/vax pt devel a cold sore & exp back pain, abd pain, cramps & flu sx;
Fleshy eyes/like little clouds in the eye on the left side/sees like cobwebs; Bothering; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Fleshy eyes/like little clouds in the eye on the left side/sees like cobwebs) and FEELING ABNORMAL (Bothering) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 008BA1) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Blood pressure high. Concomitant products included METFORMIN for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (Fleshy eyes/like little clouds in the eye on the left side/sees like cobwebs) and FEELING ABNORMAL (Bothering). The patient was treated with MATRICARIA RECUTITA (CHAMOMILEN) at an unspecified dose and frequency. At the time of the report, VISION BLURRED (Fleshy eyes/like little clouds in the eye on the left side/sees like cobwebs) and FEELING ABNORMAL (Bothering) outcome was unknown.            Concomitant medication include high blood pressure medication.  Patient experienced  fleshy (like little clouds in the eye on the left side) he sees like cobwebs, for a week.  Action taken with mRNA-1273 in response to the events were not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: TCR Received. Non significant Fu / scheduled surgery for retinol detachment on 17-Jun-21.
administered frozen Shingrix.; This case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a 59-year-old female patient who received Herpes zoster (Shingrix) (batch number C43KM, expiry date 10th April 2023) for prophylaxis.   In March 2022, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   Additional Information: GSK Receipt Date: 7-Apr-2022 Reporter's comments: The nurse administered frozen Shingrix vaccine to the patient within 7th March 2022 to 31st March 2022. The healthcare professional provided consent to follow up. Information within adverse event report was all the healthcare professional provided at this time. Additional Supportive Information: The patient received frozen Shingrix vaccine which led incorrect storage of drug. This was 1 of the 11 cases, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022061871:Same reporter. US-GLAXOSMITHKLINE-US2022061870:Same reporter. US-GLAXOSMITHKLINE-US2022061873:Same reporter. US-GLAXOSMITHKLINE-US2022061872:Same reporter. US-GLAXOSMITHKLINE-US2022061865:Same reporter. US-GLAXOSMITHKLINE-US2022061874:Same reporter. US-GLAXOSMITHKLINE-US2022061866:Same reporter. US-GLAXOSMITHKLINE-US2022061868:Same reporter US-GLAXOSMITHKLINE-US2022061864:Same reporter. US-GLAXOSMITHKLINE-US2022061860:Same reporter.
SkinRash, Rash,  Local symptoms: Pain-discomfort. General  Symptoms: Rash, Lips swelling, itching.  Narrative:    Other Relevant History:
Body aches; sneezing; coughing, runny nose lasted 36 hours.
pt recv vax & lt arm itched that day;next AM c/o inc itch, redness, swelling of upper arm, progressed almost to elbow;3MAY98 decline of itch, redness fading;21MAY98 cont to improve w/dec itch & redness;pt has lowered immune response;
I pretty much slept all day; Felt like I had a fever; Injection site is swollen and very hot; Injection area is very swollen; Injection site is swollen and very hot; Injection area is very swollen; Itches all over my arms; Severe itching; This is a spontaneous report from a contactable consumer.  A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on 17Jun2021 at 09:45 as DOSE 2, SINGLE for COVID-19 immunization. Patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported.  On an unspecified date, after the vaccination, the patient experienced sleepy and slept all day, had a fever and injection site was swollen and very hot, patient doesn't feel like running a fever. patient also got itches all over arms. On the next day also injection area was very swollen and very hot. Patient was asking what to do with the reactions. The outcome of the events was unknown.  No follow-up attempts possible. No further information expected.
03/30/2021 Two weeks after her COVID shot referred by GO to Opthamologist sent to eye doctor to see what happens. I had blurry vision, like looking underwater and peripheral vision and getting more sensitive to light, watering a lot, all to do her eyesight. General ophthalmologist retina specialist to neuropathologist, and he checked in eye for distance. Capillary of the outer edge blood leaking out of the side of her eye right was worse than the left, the nerve doctor notice the tissue in eye in both eyes was light in color. Quality of her eyesight which impacted her driving abilities. It affected walking and the fall risk and unsteady on feet.
Throat felt dry and hoarse after 15 min progressed to tongue feeling thick and hard to talk. Benadryl 50 mg IM, called, all sent to ER.
I started getting symptoms of headache that went down the side of my face, sore throat, congestion, weakness, and fatigue. I also had serious diarrhea. About the 3rd day, I started getting fever and chills. I started coughing. I tested negative for COVID-19 with a rapid test 3 days later. Then I tested positive for COVID-19 on the 5th day. I contacted my doctor with a telehealth visit and was prescribed Molnupiravir on 7/6/2022. My symptoms did get better after 24 hours. I still have a dry cough to this day. I take Nyquil and Dayquil as well.
Inappropriate age at vaccine administration; This spontaneous report as received from a registered nurse refers to a 27 year old female patient.    The patient's pertinent medical history, drug reactions, allergies or concomitant medications were not provided.  On 04-JUN-2019, the 27 year old patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (dose, route of administration, lot# and expiration date were not provided) (product administered to patient of inappropriate age). On 17-SEP-2019, the patient went back to receive the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9).
patient received a 2nd dose of Arexvy after 6 weeks of the first dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   Concomitant products included RSV VACCINE PROT. SUBUNIT PREF3 (AREXVY).   On an unknown date, the patient received the 2nd dose of Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced extra dose administered (Verbatim: patient received a 2nd dose of Arexvy after 6 weeks of the first dose). The outcome of the extra dose administered was unknown.   Additional Information: GSK receipt date: 17-OCT-2023 The pharmacist reported that patient received a 2nd dose of Arexvy after 6 weeks of the first dose, which led to extra dose administered. No more information available. The reporter did not consent to follow-up.
This spontaneous report was received from a pharmacist referring to a 74 year old female patient who was allergic to unspecified macrolide antibiotics. On 08-DEC-2015 the patient was vaccinated with a dose of ZOSTAVAX (lot # L031271, exp date 19-NOV-2016) 0.65 ml, subcutaneously. Concomitant therapies included ADDERALL and an unspecified benzodiazepine. In 2016, a month or so later, the patient developed shingles. In February 2016, the patient came in to the pharmacy and reported the reaction to her. No lab diagnostics studies were performed. At the time of the report, the outcome of event was unknown. Additional information has been requested.
One vaginal ulcer after shot 1, several days after shot 2, she developed fever then numerous painful aphthous looking ulcers that became infected requiring antibiotics. She had difficulty walking and urinating. I have researched and found an article with a 13 year old developing this after covid disease. She has psoriasis which is autoimmune.
Patient called 3 days after receiving the vaccination and stated that the vaccination site was itchy, swollen and irritated.  She us to fill out a VAERS report.
Red face; Right inner cheek twitching; This is a spontaneous report from a contactable consumer (patient). A 51-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in right arm on 22Feb2021 10:30 AM (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation. Medical history included known allergies to sulfa. The patient previously took levofloxacin and levaquin experienced allergy. Concomitant medications included zinc; krill oil; citalopram and multivitamin. No other vaccine in four weeks. The patient experienced right inner cheek twitching on 22Feb2021 and on 23Feb2021 10:30 patient had red face sun sensitivity which appeared after 24 hours and is warm to touch. There was no covid prior vaccination and covid not tested post vaccination. There was no treatment received. The outcome of event right inner cheek twitching was recovered on 23Feb2021 and outcome of event red face was unknown.  Information about lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
diffuse myalgia, arthralgia, fever, chills, changes in mental status;nausea;onset of sx-12hr lasted 48hr;
Patient felt dizzy and vision was blurry, began to seize for 10 seconds and then came to and was unable to speak for 5 minutes
Approximately 18 hours post vaccination parent noticed small red area next to injection site (L thigh). Over the next 48 hr the redness on (L) thigh extended and measured 6.5 inches diameter in office today. She has redness, warmth, swelling and tenderness to palpation. No itching. Two injection sites noted on (L) thigh, approx. 1 inch apart. The signs above are medial to both injection sites. Vaccines were given by experienced MA. I Rx cephalexin and plan to see patient back in 2 days. Dx: cellulitis, vaccine reaction.
Red circular rash around left thigh injection site that appeared two or three days after receiving immunizations on 5/16/13. Has not grown in size, but has not gone away. Injection site on right thigh shows minor bruising and no redness. Patient had difficulty walking normally secondary to pain for only one day after the injections. The pain has since resolved and she is walking normally.
Major pain in right arm Exhaustion Headache Nausea Muscle Ache Fever Regular urinating
Pt reported she had a Moderna Covid -19 vaccine on 01/09/21 at Hospital at 2: 40 pm. Pt is c/o her eyelids swelling in the last 3 days, sob this morning. Pt has ST pain constantly today that is not worse with swallowing. + fatigue since yesterday.
local site irritation; the injection received may have been subcutaneously and not intramuscularly; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received the BNT162B2 (BNT162B2, Solution for injection, lot number and expiry date not reported), subcutaneously, on an unspecified date at a single dose for COVID-19 immunization. Medical history was not reported. Concomitant medications were none. The pharmacist reported that concerns were raised if a health care provider was given vaccine SQ (subcutaneous) versus IM (intramuscular). They were investigating if needle went deep enough. The person in question seems ok other than local site irritation and was concerned that they may not have full immunity. One of their physicians, the  medical officer reported that the injection received may have been subcutaneously and not intramuscularly. They stated the administration wasn't deep enough. Outcome of the event local site irritation was unknown.  Information about lot/batch number has been requested.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash Generalized-Mild
About an hour after the vaccine, I had some strange nerve sensations on the left side of my body, including losing circulation to parts of my left hand and left foot. I woke up the morning after vaccination with much more pain in my left arm than dose 1 and flu-like symptoms. During that day, symptoms became progressively worse, with an increasing fever, chills, aches. I eventually left work to lay down when it became worse, and was very  feverish, hallucinating, and unable to sleep. Day 2 I had a migraine and body aches. Day 3 I woke up with severe hives, covering most of my face and chest, especially on the left side- my left ear was swollen to the point where it looked like I had had an accident. Day 4, all severe symptoms were gone, but I had cold symptoms (congestion, fatigue) for about a week after.
TODAY HE IS BEDRIDDEN; BODY ACHES; experienced chills; he didn't feel great after; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (he didn't feel great after), BEDRIDDEN (TODAY HE IS BEDRIDDEN), PAIN (BODY ACHES) and CHILLS (experienced chills) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A.) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 ml. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 ml. On 02-Mar-2021, the patient experienced FEELING ABNORMAL (he didn't feel great after) and CHILLS (experienced chills). On 02-Apr-2021, the patient experienced BEDRIDDEN (TODAY HE IS BEDRIDDEN) and PAIN (BODY ACHES). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 03-Mar-2021, FEELING ABNORMAL (he didn't feel great after) and CHILLS (experienced chills) had resolved. At the time of the report, BEDRIDDEN (TODAY HE IS BEDRIDDEN) and PAIN (BODY ACHES) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   TREATMENT DRUG TYLENOL WAS USED THE LAST TIME AROUND FOR SIDE EFFECTS CONCOMINANT DRUGS WERE NOT PROVIDED
Two patients received Moderna vaccines 15 days after expiration date.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Two patients received Moderna vaccines 15 days after expiration date.) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Jan-2022 at 11:00 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Two patients received Moderna vaccines 15 days after expiration date.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Two patients received Moderna vaccines 15 days after expiration date.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information provided. The vial did not undergo any temperature excursions. Date the vial was initially stored in the refrigerator: Unknown The patient not experienced any physical adverse reaction and was notified regarding the expired vaccine and would came to clinic to get a repeat booster. The patient receives the booster as 0.25 of unknown unit. The patient had no known allergies. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2022: Significant follow up appended: Report type updated, Reporter information updated (city and postal code), Patient demographics updated, Dosage information updated and Product coding updated.
Moderna COVID-19 Vaccine EUA  Headache and tiredness for 4 days and counting  Rash appeared on the 4th day
Lack of Appetite, diarrhea, vomiting. Called Dr. on call. Dr told me to keep an eye on him, not give him food and if he continued throwing up after a few hours to take him in. He threw up 5 times total. I gave him water and watched him during the night. On the morning of 3/6/2015, he breastfed a little, but would only eat small amounts. Took two 3.5 hour naps and is currently sleeping again. I do not know that he has recovered yet, since he is still not acting normally. I am continuing to keep an eye on him.
PT. HAD NO MAJOR ADVERSE EVENTS, BUT EXPERIENCED FATIGUE. PT. RECEIVED A VACCINE THAT WAS ADMINSTERED PASSED RECOMMENDED EXPIRATION DATE.
About 24 hours after administration of the varicella vaccine subcutaneously to my right upper arm I developed an area of erythema and warmth. The area spread to about 10cm in diameter. The area was not tender. It resolved without intervention 36 hours after it appeared.
After first and second shots, experienced a moderate burning sensation in feet and toes the first night. Lasted a couple of hours. No other side effects. I have never had that sensation before.; This is a spontaneous report received from a contactable consumer (Patient). A 67-year-old non pregnant female patient received first and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in arm left on 06Feb2021 15:00 (Lot Number: EN6201) as first dose single and via an unspecified route of administration, administered in arm left on 05Mar2021 (Lot Number: EL9266) as second dose single for covid-19 immunisation. Medical history included known allergies: Penicillin. Concomitant medications included losartan, atorvastatin, omeprazole and anastrozole. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 Prior to vaccination. The patient had not been tested for COVID-19 Since the vaccination. On 06Feb2021 22:30, after first and second shots, patient experienced a moderate burning sensation in feet and toes the first night. Lasted a couple of hours. No other side effects. She never had that sensation before. No treatment was received. The event was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Information has been received from a registered nurse concerning a female who was vaccinated IM with a 0.5 mL dose of Gardasil. Subsequently, post vaccination, the patient experienced tingling of the same arm she was vaccinated. The patient sought unspecified medical attention. The patient's outcome was unknown. Additional information has been requested.
<10 minutes after vaccination, patient had syncope episode, fall broken by another person, slight bump to head. Patient became conscious, was seated on a chair, and then had second syncope episode followed with convulsions. Stabilized patient. Vitals monitored, assessed by MD and released with referral to PCP.
Swollen,  big knot . Red all they way around can?t move arm hurts to touch and sit is hot to touch.
Patient became nauseated and pale after receiving her first vaccine. Patients vital signs were evaluated and patient was kept for an  extra 15 minutes. Patients mom was advised that if her symptoms continued to either take her to her family doctor or an urgent care or call  EMS if her symptoms became worse. As her symptoms did not completely go away prior to leaving.
"Large rash that is warm to the touch on the top of (R) arm and that arm is swollen at injection site." Also says arm is sore.